The U.S. is of two minds when it comes to BPA, a chemical that’s in everything from dental fillings to baby bottles: An NIH panel found “some concern” that BPA is dangerous to human health, but the FDA declared it safe (even though FDA scientists questioned the rigor of this investigation). According to Fast Company, the chemical industry has employed “big tobacco’s tactics” to sow doubt about BPA’s health hazards and evade regulation.
Even as Obama fends off criticism about his ethics standards, he might be set to welcome another lobbyist into his administration, reports today’s Los Angeles Times. Until last year, Mark Gitenstein, Obama’s likely nominee to head the Justice Department’s Office of Legal Policy, was a lobbyist for the U.S. Chamber of Commerce, which has pushed hard for judicial nominees and legislation that “would make it harder for plaintiffs to sue large corporations.” The Office of Legal Policy oversees legal policy and judicial nominations, reports the Times.
Thank you for your interest in republishing this story. You are are free to republish it so long as you do the following:
You have to credit us. In the byline, we prefer “Author Name, ProPublica.” At the top of the text of your story, include a line that reads: “This story was originally published by ProPublica.” You must link the word “ProPublica” to the original URL of the story.
If you’re republishing online, you must link to the URL of this story on propublica.org, include all of the links from our story, including our newsletter sign up language and link, and use our PixelPing tag.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week,” and “Portland, Ore.” to “Portland” or “here.”)
You cannot republish our photographs or illustrations without specific permission. Please contact [email protected].
It’s okay to put our stories on pages with ads, but not ads specifically sold against our stories. You can’t state or imply that donations to your organization support ProPublica’s work.
You can’t sell our material separately or syndicate it. This includes publishing or syndicating our work on platforms or apps such as Apple News, Google News, etc.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually. (To inquire about syndication or licensing opportunities, contact [email protected].)
You can’t use our work to populate a website designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
We do not generally permit translation of our stories into another language.
Any website our stories appear on must include a prominent and effective way to contact you.
If you share republished stories on social media, we’d appreciate being tagged in your posts. We have official accounts for ProPublica on Twitter, Facebook and Instagram.
Copy and paste the following into your page to republish: